Native Mass Spectrometry Dissects the Structural Dynamics of an Allosteric Heterodimer of SARS-CoV-2 Nonstructural Proteins-Reference-Cited by-同舟云学术

Native Mass Spectrometry Dissects the Structural Dynamics of an Allosteric Heterodimer of SARS-CoV-2 Nonstructural Proteins

Published:2024-03-27 Issue:5 Volume:35 Page:912-921
ISSN:1044-0305
Container-title:Journal of the American Society for Mass Spectrometry
language:en
Short-container-title:J. Am. Soc. Mass Spectrom.

Author:

Thibert Stephanie M.¹,Reid Deseree J.²,Wilson Jesse W.¹^ORCID,Varikoti Rohith³,Maltseva Natalia⁴⁵,Schultz Katherine J.³,Kruel Agustin³^ORCID,Babnigg Gyorgy⁴⁶^ORCID,Joachimiak Andrzej⁴⁵,Kumar Neeraj³^ORCID,Zhou Mowei¹^ORCID

Affiliation:

1. Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington 99354, United States

2. Chemical and Biological Signature Sciences, Pacific Northwest National Laboratory, Richland, Washington 99354, United States

3. Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99354, United States

4. Center for Structural Biology of Infectious Diseases, Consortium for Advanced Science and Engineering, University of Chicago, Chicago, Illinois 60637, United States

5. Structural Biology Center, X-ray Science Division, Argonne National Laboratory, Argonne, Illinois 60439, United States

6. Biosciences Division, Argonne National Laboratory, Argonne, Illinois 60439, United States

Funder

Environmental Molecular Sciences Laboratory

National Institute of Allergy and Infectious Diseases

Office of Science

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/jasms.3c00453

Reference61 articles.

1. A Structure-Based Drug Discovery Paradigm

2. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery

3. Artificial Intelligence for Autonomous Molecular Design: A Perspective

4. AI-Accelerated Design of Targeted Covalent Inhibitors for SARS-CoV-2

5. Integrated data-driven and experimental approaches to accelerate lead optimization targeting SARS-CoV-2 main protease